Trademarkia Logo

Canada

C$
ADC THERAPEUTICS
APPROVED

on 6 Feb 2025

Last Applicant/ Owned by

ADC Therapeutics SA

Route de la Corniche, 3BCH-1066 Epalinges

CH

Serial Number

2141279 filed on 3rd May 2021

Correspondent Address

OSLER, HOSKIN & HARCOURT LLP

Suite 320, World Exchange Plaza100 Queen StreetOttawa,

ONTARIO

CA

K1P1J9

ADC THERAPEUTICS

Trademark usage description

pharmaceutical preparations for use in the prevention and treatment of infectious and inflammatory diseases, disorders, and conditions related to canc Read More

Vienna Information


26 . 11 . 1

One line or one bandUne ligne ou une bande

26 . 11 . 6

Thick lines, bandsLignes épaisses, bandes

26 . 11 . 8

Horizontal lines or bandsLignes ou bandes horizontales

26 . 11 . 13

Wavy lines or bands, zigzag lines or bandsLignes ou bandes ondulées, en dents de scie

27 . 5 . 1

Letters presenting a special form of writingLettres présentant un graphisme spécial

27 . 5 . 11

Letters underlined, overlined, framed or barred by one or more strokesLettres soulignées, surlignées, encadrées ou barrées d'un ou de plusieurs traits

27 . 5 . 8

Letters linked to or containing a figurative element -- Note: Letters representing a human being or a part of the human body, an animal or a part of an animal's body, a plant, a heavenly body, a natural phenomenon or an object are classified in division 27.3.Lettres liées à un élément figuratif ou contenant un élément figuratif -- Note: Les lettres représentant un être humain ou une partie du corps humain, un animal ou une partie du corps d'un animal, un végétal, un corps céleste, un phénomène naturel ou un objet sont classées dans la division 27.3.

27 . 5 . 22

Monograms formed of intertwined, overlapping or otherwise combined lettersMonogrammes formés par des lettres enlacées, se chevauchant ou combinées autrement

25 . 12 . 3

Moiré surfaces or backgroundsSurfaces ou fonds moirés

Classification Information


Class [005]
Pharmaceutical preparations for use in the prevention and treatment of infectious and inflammatory diseases, disorders, and conditions related to cancer and cancerous tumors, and oncological, inflammatory, immune, autoimmune, genetic, and rare oncological, immune, autoimmune, and genetic diseases, disorders, and conditions; anti-inflammatories; anti-infectives, pharmaceutical preparations for human use, namely, pharmaceutical antibodies, pharmaceutical preparations for use in immunotherapies, pharmaceutical preparations, biological preparations, and gene therapy products in the nature of pharmaceutical and biological substances for the treatment of infectious and inflammatory diseases, disorders, and conditions related to cancer and cancerous tumors, and oncological, immune, auto-immune, genetic, and rare oncological, immune, auto-immune, and genetic diseases, disorders, and conditions, pharmaceutical preparations made from antibody-drug conjugates for conditioning patients to receive immunotherapies for the treatment of infectious and inflammatory diseases, disorders, and conditions related to cancer and cancerous tumors, and oncological, immune, auto-immune, genetic, and rare oncological, immune, auto-immune, and genetic diseases, disorders, and conditions; pharmaceutical preparations for use in the prevention and treatment of cancer and tumors; diagnostic preparations for medical purposes for detecting cancer and cancerous tumours; diagnostic agents, preparations, and substances for detecting cancer and cancerous tumours; diagnostic kits comprised of medical diagnostic reagents and assays for testing of human tissue for use in the detection of infectious and inflammatory diseases, disorders, and conditions related to cancer and cancerous tumors, and, oncological, immune, auto-immune, genetic, and rare oncological, immune, auto-immune, and genetic diseases, disorders, and conditions, diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious and inflammatory diseases, disorders, and conditions related to cancer and cancerous tumors, and oncological, immune, auto-immune, genetic, and rare oncological, immune, auto-immune, and genetic diseases, disorders, and conditions, diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans; diagnostic biomarker reagents for medical purposes, reagents for medical use, medical diagnostic assays for testing body fluids, medical diagnostic assays for testing body tissue.


Classification kind code

11

Class [042]
Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals.


Classification kind code

11

Class [044]
Providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, and health.


Classification kind code

11

Mark Details


Serial Number

2141279

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 48
on 24th Jul 2023
Agent Changed
Submitted for opposition 22
on 26th Jan 2023
Search Recorded
Submitted for opposition 20
on 26th Jan 2023
Examiner's First Report
Submitted for opposition 223
on 26th Jan 2023
Total Provisional Refusal
Submitted for opposition 256
on 22nd Aug 2022
Notification of Possible Opposition Sent
Submitted for opposition 257
on 21st Oct 2021
Designation Notification - Madrid Protocol
Submitted for opposition 31
on 20th Oct 2021
Formalized
Submitted for opposition 1
on 20th Oct 2021
Created
Submitted for opposition 228
on 3rd May 2021
International Registration
Submitted for opposition 30
on 3rd May 2021
Filed